Edition:
United Kingdom

Getinge AB (GETIb.ST)

GETIb.ST on Stockholm Stock Exchange

84.96SEK
18 May 2018
Change (% chg)

-0.04kr (-0.05%)
Prev Close
85.00kr
Open
85.00kr
Day's High
85.54kr
Day's Low
84.36kr
Volume
1,710,355
Avg. Vol
1,707,120
52-wk High
182.06kr
52-wk Low
81.66kr

Chart for

About

Getinge AB is a Sweden-based company active in the healthcare sector. It provides products and services for intensive care units, sterilization centers, elderly care and companies and institutions active in the life sciences area. Its operations are divided into three business areas: The Medical Systems business area offers... (more)

Overall

Beta: 1.22
Market Cap(Mil.): kr39,673.18
Shares Outstanding(Mil.): 254.15
Dividend: 1.97
Yield (%): 1.26

Financials

  GETIb.ST Industry Sector
P/E (TTM): 33.22 32.19 32.75
EPS (TTM): 4.70 -- --
ROI: 2.53 13.89 14.38
ROE: 5.94 16.72 16.07

Getinge to step up cost cuts after deeper-than-expected Q1 loss

STOCKHOLM, April 26 Swedish medical technology group Getinge said on Thursday it would step up cost cuts after it reported a bigger than expected operating loss for the first quarter, sending its shares down nearly 5 percent.

26 Apr 2018

BRIEF-Getinge Q1 operating result lags forecast

* Q1 OPERATING PROFIT (EBIT) AMOUNTED TO SEK -161 M (302), CURRENCY EFFECTS HAD A NEGATIVE IMPACT OF SEK -115 M ON EBIT

26 Apr 2018

Getinge makes another provision for Brazil fraud probe

STOCKHOLM, March 21 Swedish medical technology group Getinge said on Wednesday it would book a 350 million crown ($42.6 million) provision in the first quarter related mainly to a fraud probe in Brazil.

21 Mar 2018

Getinge core profit lags forecast, sees slight growth in 2018

STOCKHOLM, Jan 29 Swedish medical technology group Getinge on Monday reported a fourth-quarter core profit far below market forecasts and said it expected slight growth in organic sales this year.

29 Jan 2018

BRIEF-Getinge Q4 core profit far below forecast​

* Q4 ‍EBITA 1** AMOUNTED TO SEK 1,111 M (1,689) WITH AN EBITA 1 MARGIN OF 15.1% (22.7)​

29 Jan 2018

Earnings vs. Estimates